Slenyto
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Slenyto, covering 2021-03-12 to 2026-06-10. Get the full timeline:
Most recent: EMA Authorised: Slenyto (melatonin) — RAD Neurim Pharmaceuticals EEC SARL